Exploring AI's Role in 2024

Exploring AI's Role in 2024

In this newsletter:

  • NyquistAI Insights: Global data and intelligence from our platform
  • Upcoming Webinar! Exploring AI's Role in 2024
  • Use Case Spotlight: Insights into Global Clinical Trials
  • Product Highlight of the Month: NyquistIQ - AI for your documents and data
  • This Month in AI, MedTech, & Biopharma: The Future of AI?


Nyquist Insights

January 2024 insights from the NyquistAI data platform

To gain further insights like these and discover the full potential of our platform, schedule an introductory meeting with one of our product experts to learn more.

SCHEDULE A DEMO!


WEBINAR OVERVIEW

In 2023, Generative AI (GenAI) took center stage, revolutionizing industries worldwide. Now, in 2024, we're witnessing its continued evolution, with specialized solutions tailored for specific sectors, particularly in life sciences.

Join us Wednesday, February 28th as we explore practical approaches, real-world use cases, and success stories from the forefront of AI adoption in life sciences.

YOU WILL LEARN:

  • Strategic Integration of AI in Life Sciences: Gain insights into strategically integrating AI across life sciences, navigating challenges, and maximizing opportunities for innovation.
  • Navigating Challenges and Maximizing Opportunities: Highlight challenges and opportunities in AI adoption, including regulatory and ethical considerations, for the life sciences industry.
  • Creating Value While Mitigating Risks: Learn practical strategies to create value while mitigating risks in AI implementation through real-world success stories and lessons.

-> REGISTER TODAY! <-


Use Case Spotlight

Effortlessly review and extract insights from global clinical trials

  • PAIN POINTS: Clinical Trial Landscape, Global Markets
  • VERTICALS: Manufacturers, Consultants, CROs
  • FUNCTIONAL AREAS: Regulatory, Clinical, Medical Affairs

PROBLEM

Evaluating global trials can be a difficult and time-consuming task, with not enough information available or easily accessible, particularly in markets like China and Japan.

SOLUTION

With Nyquist's truly global database of trial registries, effortlessly search and segment the global trial landscape. In the Nyquist data platform, you'll find 30% more trials than ClinicalTrials.gov, including comprehensive coverage of China, Japan, Australia/New Zealand, Israel, and more.

View trials by phase, enrollment number, intervention type (including biologic, device, or combination product), and more. In a few clicks, summarize the trials of interest in clean, informative tables with Nyquist's document writer.

VALUE

Expand your understanding of the global landscape and get the competitive edge on emerging markets with Nyquist's comprehensive access to international trials with English translations.


NYQUISTAI PRODUCT HIGHLIGHT

Introducing: NyquistIQ

Data is the new currency in the life sciences industry, but it can be hard to make sense of it all. NyquistIQ uses Generative AI to simplify data analysis and empower knowledge professionals to focus on what matters.

WHY OUR AI?

  • Industry Expertise: Our AI comprehends the intricacies of life sciences data, making it an invaluable asset for professionals in pharmaceuticals, biotechnology, and healthcare.
  • Security First: Worried about data privacy? Rest assured that your information remains confidential and secure. Our AI respects your privacy and ensures that your data stays yours.
  • Transparent: Ever wondered where an AI-generated answer came from? Our solution provides transparency by pointing back to the relevant sources. No more black boxes!

HOW CAN YOU USE IT?

  • Individuals: Whether you’re a researcher, analyst, or consultant, our AI can assist you in extracting insights from your documents. Simply upload a file and start asking questions.
  • Departments and Organizations: Scale up! Our AI can be applied across your entire team or organization. Imagine unlocking hidden knowledge from dormant data silos.

Our cutting-edge AI solution, NyquistIQ, has been meticulously trained over the past three years, drawing from over 1 billion data points specifically from the life sciences industry. Unlike any other AI out there, it understands the nuances unique to this field.

Ready to Explore? Schedule A Meeting With Us!


THIS MONTH IN AI, MEDTECH, & BIOPHARMA

AI Isn't The Problem, It's The Solution: TED Talk by Andrew Ng

In a recent TED talk, renowned AI expert Andrew Ng dissected the rapidly evolving landscape of artificial intelligence (AI), shedding light on its potential benefits and looming challenges. Drawing parallels to historical technological advancements, Ng explored the duality of excitement and apprehension surrounding AI's development. Here are three points from the TED Talk:

1. Harnessing AI's Potential:

Ng delved into the transformative power of AI, likening it to the advent of electricity and its eventual integration into daily life. He emphasized AI's ability to democratize access to intelligence and guidance, offering more accessible and affordable solutions for individuals and society as a whole.

2. Mitigating Risks:

Despite its promise, Ng addressed the pressing concerns surrounding AI, including job displacement, the exacerbation of negative human traits, and existential threats. He stressed the importance of leveraging AI to tackle global issues such as climate change and pandemics while highlighting the need for responsible and ethical development.

3. Addressing Societal Anxieties:

Ng acknowledged the reflection of broader societal anxieties in the discourse surrounding AI development. He emphasized the imperative for continued improvement in current AI systems to address their flaws and foster public trust, ultimately advocating for a balanced and ethical approach to AI advancement.

Click here to see the 13-minute TED talk.


VSP Vision Releases New Report on the 'Future of Generative AI in Healthcare'

The rapid advancement of generative AI in healthcare offers significant potential for transformation, encompassing system integration, patient empowerment, workflow automation, improved medical devices, and ethical considerations. A recent report published by the VSP Global Innovation Center, highlights five emerging trends shaping the future of generative AI in healthcare:

1. System Cohesion for Shared Care: Generative AI facilitates the translation of unstructured medical data, enabling seamless data-sharing and interoperability among healthcare technologies. This integration breaks down organizational silos and accelerates clinical trial processes, promoting unified care delivery.

2. Empowered Patients Leading to Better Outcomes: AI-driven tools personalize and automate various touchpoints in the patient journey, improving accessibility to verified health information and enhancing health literacy. Additionally, generative AI aids patients with disabilities by improving access to assistive services.

3. In-Practice Solutions Alleviating Provider Burnout: AI-powered tools assist healthcare workers in tasks such as medical note-taking and disease screening, reducing cognitive load and providing real-time guidance. Natural language processing (NLP) technology facilitates research by navigating large volumes of medical data.?

4. Embedded Generative AI Transforming Medical Devices: Generative AI enables the development of advanced medical imaging tools that improve diagnostics and predict health outcomes. This technology supports medical workflows, enhancing safety during surgeries and providing tailored treatment plans.

5. "Big, Bad AI" Supporting Good Behavior: AI facilitates empathetic conversations with patients and automates compliance processes, improving the overall healthcare experience while ensuring governance and privacy protection. Synthetic data usage enhances representation in medical research and addresses health inequities.

Click here to see read the full report


Interested to see how NyquistAI can give you a competitive advantage in 2024?

Contact Us Today!


要查看或添加评论,请登录

NyquistAI的更多文章

社区洞察

其他会员也浏览了